Keros Therapeutics, Inc.KROSNASDAQ
Loading
Net Income ScalingExpanding
Percentile Rank100
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

Latest
$87.01M
↑ 246% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthExpanding
Average
$-59.47M
Historical baseline
PeriodValueYoY Change
2025$87.01M+146.4%
2024$-187.35M-22.5%
2023$-152.99M-46.2%
2022$-104.68M-78.2%
2021$-58.74M-29.5%
2020$-45.36M-267.5%
2019$-12.34M-824.6%
2018$-1.33M-